Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth
The Bristol Myers Squibb Q3 2026 results lift revenue guidance as newer drugs grow 12%. EPS fell on a $1.6 billion charge.
Ebola Outbreak October 2026: DRC Spread Alarms, Kenya Cases
Ebola outbreak October 2026: DR Congo names a North Ubangi eighth province and Kenya confirms an eighth case. Locations, counts and what is official.
Cancer Medicine Price Reduction in India: Bold Cap Nov 9
Cancer medicine price reduction in India: NPPA caps trade margins at 30% on 137 drugs from 9 November 2026. What changes, and what up to 70% means.
Europe Teeth Cleaning Machine Market to Top USD 1 Billion by 2032
The Europe teeth cleaning machine market was valued at USD 572.6 million in 2023 and will surpass USD 1,006.1 million by 2032, a 6.7% CAGR, says Acumen.
Continuous Glucose Monitoring for Type 2 Diabetes: Promising
Continuous glucose monitoring for Type 2 diabetes cut HbA1c more than routine care in the Dexcom-sponsored CONNECT trial. What it shows, and its limits.
Mankind Pharma CAR-T Acquisition: Bold €48M Cancer Bet
Mankind Pharma CAR-T acquisition: a 70% stake in Armed Cell Therapeutics for €48 million. What it buys, and why the assets are still in development.
South Africa GLP-1 Compounding Regulations: Crackdown Looms
South Africa GLP-1 compounding regulations are being rewritten. What the pharmacy council and SAHPRA plan, the timetable, and what is law today.
VQW-765 Clinical Trial Results: Disappointing Phase 3 Miss
VQW-765 clinical trial results: Vanda’s Phase 3 social anxiety study missed its goals and the programme is on hold. What the data show.
550-Bed Hospital in Prayagraj: Bold ₹200 Crore Build
550-bed hospital in Prayagraj: Park Hospital breaks ground on a ₹200 crore PPP project. Timeline, terms, group expansion plans and caveats.
Pennsylvania Measles Cases Reach 1,222: Alarming Surge
Pennsylvania measles cases reached 1,222 on 14 October, with 225 hospitalisations and five deaths. What the state data show and what to do.
AVID Medical IV Start Kit Class I Recall: Urgent Risk
AVID Medical IV start kit Class I recall: lot 1658437 (KRIV26-02) may hold fungus-contaminated applicators. Who is affected and what to do now.